Biosimilar to biosimilar infliximab switching in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry: Switch from originator infliximab to CT-P13 and then to GP1111

Hafsah Nabi; Bente Glintborg; AG Loft; O Hendricks; JK Pedersen; SA Just; Rabiah Ahmed; Kamilla  Danebod; H Munk; A Colic; A Linauskas; Dorte Vendelbo Jensen; J Raun; J Grydehøj; LB Christensen; Natalia Manilo; N Lomborg; S Kristensen; F Mehnert; NS Krogh; Merete Lund Hetland

Biosimilar to biosimilar infliximab switching in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry: Switch from originator infliximab to CT-P13 and then to GP1111

Hafsah Nabi, Bente Glintborg, AG Loft, O Hendricks, JK Pedersen, SA Just, Rabiah Ahmed, Kamilla Danebod, H Munk, A Colic, A Linauskas, Dorte Vendelbo Jensen, J Raun, J Grydehøj, LB Christensen, Natalia Manilo, N Lomborg, S Kristensen, F Mehnert, NS KroghMerete Lund Hetland

Original language	English
Article number	0573
Journal	Arthritis and Rheumatology
Volume	73
Issue number	No. S9
Pages (from-to)	1161-3
Number of pages	3
ISSN	2326-5191
Publication status	Published - 2021

Cite this

Nabi, H., Glintborg, B., Loft, AG., Hendricks, O., Pedersen, JK., Just, SA., Ahmed, R., Danebod, K., Munk, H., Colic, A., Linauskas, A., Jensen, D. V., Raun, J., Grydehøj, J., Christensen, LB., Manilo, N., Lomborg, N., Kristensen, S., Mehnert, F., ... Hetland, M. L. (2021). Biosimilar to biosimilar infliximab switching in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry: Switch from originator infliximab to CT-P13 and then to GP1111. Arthritis and Rheumatology, 73(No. S9), 1161-3. Article 0573.

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Nabi, H , Glintborg, B, Loft, AG, Hendricks, O, Pedersen, JK, Just, SA, Ahmed, R, Danebod, K, Munk, H, Colic, A, Linauskas, A, Jensen, DV, Raun, J, Grydehøj, J, Christensen, LB, Manilo, N, Lomborg, N, Kristensen, S, Mehnert, F, Krogh, NS & Hetland, ML 2021, 'Biosimilar to biosimilar infliximab switching in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry: Switch from originator infliximab to CT-P13 and then to GP1111', Arthritis and Rheumatology, vol. 73, no. No. S9, 0573, pp. 1161-3.

@article{a045b27297ee4e4584b628cfe655e093,

title = "Biosimilar to biosimilar infliximab switching in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry: Switch from originator infliximab to CT-P13 and then to GP1111",

author = "Hafsah Nabi and Bente Glintborg and AG Loft and O Hendricks and JK Pedersen and SA Just and Rabiah Ahmed and Kamilla Danebod and H Munk and A Colic and A Linauskas and Jensen, {Dorte Vendelbo} and J Raun and J Grydeh{\o}j and LB Christensen and Natalia Manilo and N Lomborg and S Kristensen and F Mehnert and NS Krogh and Hetland, {Merete Lund}",

note = "COPECARE",

year = "2021",

language = "English",

volume = "73",

pages = "1161--3",

journal = "Arthritis and Rheumatology",

issn = "2326-5191",

publisher = "John Wiley and Sons Ltd",

number = "No. S9",

}

TY - ABST

T1 - Biosimilar to biosimilar infliximab switching in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry: Switch from originator infliximab to CT-P13 and then to GP1111

AU - Nabi, Hafsah

AU - Glintborg, Bente

AU - Loft, AG

AU - Hendricks, O

AU - Pedersen, JK

AU - Just, SA

AU - Ahmed, Rabiah

AU - Danebod, Kamilla

AU - Munk, H

AU - Colic, A

AU - Linauskas, A

AU - Jensen, Dorte Vendelbo

AU - Raun, J

AU - Grydehøj, J

AU - Christensen, LB

AU - Manilo, Natalia

AU - Lomborg, N

AU - Kristensen, S

AU - Mehnert, F

AU - Krogh, NS

AU - Hetland, Merete Lund

N1 - COPECARE

PY - 2021

Y1 - 2021

M3 - Conference abstract in journal

SN - 2326-5191

VL - 73

SP - 1161

EP - 1163

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

IS - No. S9

M1 - 0573

ER -